Health

World Federation of Hemophilia (WFH) publishes "The WFH Guidelines for the Management of Hemophilia, 3rd edition"

MONTREAL, Aug. 4, 2020 /PRNewswire/ -- Led by content leads, Alok Srivastava, MD, andGlenn Pierce, MD, PhD, WFH Vice-President, Medical, this 3rd edition of the World Federation of Hemophilia (WFH) Guidelines for the Management of Hemophilia offers up-to-date guidance and practical recommendation...

2020-08-04 17:00 2306

WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor

SHANGHAI, Aug. 4, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it was awarded as "Most Honored Company" byInstitutional Investor , an international financial publication, based on the strength o...

2020-08-04 17:00 2362

Panchshil Realty's Office Portfolio First in APAC To Meet British Safety Council's Global Benchmarks for COVID-19 Related Control Measures

PUNE, India, Aug. 4, 2020 /PRNewswire/ -- Panchshil Realty and British Safety Council today announced a new milestone in workplace safety in the corporate real estate sector inIndia in the context of COVID-19 and safe return to work. Panchshil Realty has become the first and only real estate gro...

2020-08-04 16:59 3576

AXA Hong Kong launches additional coverage for COVID-19

HONG KONG, Aug. 4, 2020 /PRNewswire/ -- In light of the ongoing spread of the Coronavirus Disease 2019 (COVID-19), AXA Hong Kong is now offering the following enhanced coverage and services to its customers to give them a peace of mind. New COVID-19 policy coverage and benefits, including: * ...

2020-08-04 16:30 5518

Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheter

LAGUNA HILLS, California, Aug. 4, 2020 /PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AFib) and ventricular tachycardia (VT), and developer of theintelligent Continuous Lesion Ablation System (iCLAS™), today announced successful pre-clinical re...

2020-08-04 10:16 2752

Macrogen Obtains Europe's CE-IVD Certificate for its COVID-19 Test Kit

SEOUL, South Korea, Aug. 4, 2020 /PRNewswire/ -- The Korean biotech company Macrogen (CEO Sukang Lee), announced on the 3rd that it had obtained the CE marking forEurope's In-Vitro Diagnostic (CE-IVD) devices for its coronavirus disease 2019 (COVID-19) test kit 'Axen™...

2020-08-04 10:00 3950

iHerb Announces Major Enhancement to iHerb's Popular Rewards Program

PASADENA, California, Aug. 4, 2020 /PRNewswire/ -- Global health and beauty e-commerce leader iHerb is revamping its Rewards Program to deliver better returns to loyal customers and those they refer to experience iHerb's superior line of products delivered at superior prices with superior service...

2020-08-04 04:55 2673

TB Alliance Announces European Commission Authorisation of New Treatment for Highly Drug-Resistant Tuberculosis

Pretomanid, developed by the non-profit TB Alliance, has received EU marketing authorisation in combination regimen with bedaquiline and linezolid in adults with XDR-TB or treatment-intolerant/non-responsive MDR-TB PRETORIA, South Africa, Aug. 3, 2020 /PRNewswire/ -- Pretomanid, a novel compound...

2020-08-03 21:13 2884

GranBio and NextChem sign partnership to develop cellulosic ethanol market

SAO PAULO and ROME, Aug. 3, 2020 /PRNewswire/ -- GranBio, a 100% Brazilian industrial biotechnology company, and NextChem, Maire Tecnimont's subsidiary for energy transition announced a strategic partnership to achieve global leadership in the licensing of patented GranBio 2G Ethanol technology t...

2020-08-03 20:54 3378

World's First 3D Regenerative Implant and Regenerative Surgical Technique To Regrow Man's Skull

SINGAPORE, Aug. 3, 2020 /PRNewswire/ -- Osteopore International Pte Ltd, a Singapore-headquartered company leading the way in regenerative bone implants, is proud to announce the success of its technology in a new medical procedure that took place inBrisbane, Australia, in December last year. Pio...

2020-08-03 14:00 3372

Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China

SUZHOU, China, Aug. 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dise...

2020-08-03 08:00 8152

/C O R R E C T I O N -- Infineon/

In the news release, "Accurate, anonymous, contactless: Infineon's radar-based entrance counter solution for public buildings, retail stores, restaurants or corporate spaces", issued on July 28, 2020 by Infineon over PR Newswire, we are advised by the company that the dimension of the discrete ra...

2020-07-31 18:04 11840

Brain Navi Develops New Robot Performing Nasal Swab Tests to Prevent Cross Infections

HSINCHU, July 31, 2020 /PRNewswire/ -- Inspired by the pandemic, Brain Navi developed a new robot to perform nasal swab tests autonomously to prevent cross infections so we can save the medical system and reestablish economies. The coronavirus caused the lock-in policy over the world. To reopen a...

2020-07-31 15:19 4347

OCB Life Supports the 10-day, 2,600km "Trans-Vietnam Charity Run" to Bring Life-changing Smiles for Children

HO CHI MINH CITY, Vietnam, July 31, 2020 /PRNewswire/ -- OCB Life has supported VND 900 million (equivalent to USD 38,800) to the "Trans-Vietnam Charity Run" organized by Operations Smile Vietnam and Vietnam Ekiden. Operation Smile, a nonprofit organization, has provided over 220,000 free surger...

2020-07-31 09:00 6040

Harbour BioMed Announces Strategic Partnership with Viva Biotech to Collaborate on Incubating Innovative Biotech Start-ups

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, SHANGHAI, China, July 31, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global clinical stage biopharmaceutical company and Viva Biotech (Shanghai) Ltd. ("Viva Biotech"), a world-leading structure-based drug discovery platform today announced...

2020-07-31 08:56 5005

Ascletis' All-oral HCV Treatment Approved for Marketing in China

HANGZHOU and SHAOXING, China, July 31, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that its all-oral HCV treatment has been approved for marketing inChina by National Medical Products Administration (NMPA). The Company's all-oral HCV treatment (RDV/DNV Regimen) is ...

2020-07-31 08:47 9598

INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

- INO-4800 showed durable antibody and T cell responses in rhesus macaques for 4 months - INO-4800 is the only vaccine to demonstrate long-term protection in non-human primates challenged with SARS-CoV-2 virus 13 weeks from vaccination  - Memory T and B cell responses resulted in reduced viral l...

2020-07-30 20:34 5671

LimaCorporate Is The First Italian Company To Obtain The EU Quality Certificate Under The MDR

SAN DANIELE DEL FRIULI, Italy, July 30, 2020 /PRNewswire/ -- LimaCorporate announces that it is the first Italian company to obtain the EU Quality Management System certificate under the new European Medical Devices Regulation (MDR) from TÜV SÜD. In 2015, LimaCorporate formalized the development ...

2020-07-30 20:00 3902

Esaote and WDM Ink Agreement on Digital Radiology

Esaote won a major contract in Italy in March Under a partnership with WDM, Esaote expands its range and boosts its capacity to respond to the demands of the international market. GENOA, Italy, July 30, 2020 /PRNewswire/ -- In the thick of the Covid-19 emergency,Esaote, an Italian world leader i...

2020-07-30 19:00 3931

Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies

Study published in Nature shows J&J's investigational SARS-CoV-2 vaccine elicits a strong immune response that protects against subsequent infection First-in-human Phase 1/2a clinical trial now underway in United States and Belgium; Phase 3 clinical trial expected to commence in September NEW BR...

2020-07-30 17:55 10115
1 ... 440441442443444445446 ... 562